Half for and half against! GSK "Dapstal" has a difficult road to listing in the United States
Time of Update: 2022-10-31
On October 26, the FDA held an advisory committee meeting on Daprodustat, GSK's oral chronic kidney disease anemia (CKD) drug, and the mixed vote was mixed, half for and half against.
SOHO 2022: Pacritinib improves transfusion-dependent anemia by inhibiting ACVR1 in myelofibrosis
Time of Update: 2022-10-19
FDA approval for marketing, see: FDA approves new myelofibrosis drug pacritinibAccording to the results of a retrospective analysis of the Phase 3 PERSIST-2 trial (NCT02055781) presented at the 10th Annual Meeting of the American Society of Hematology-Oncology (SOHO), pacritinib treatment improved transfusion dependence and hemoglobin in patients with myelofibrosis.
Zhou Caicun's team won the 2022 WCLC Cancer Treatment Team Award, the only one in Asia
Time of Update: 2022-08-19
The team of Professor Zhou Caicun, Department of Oncology, Shanghai Pulmonary Hospital, won the Cancer Treatment Team Award (CCTA) issued by the International Association for the Study of Lung Cancer (IASLC), becoming the four recipients of the award in the world this year.
What new developments are worth paying attention to at the opening of the gene and cell therapy industry conference today
Time of Update: 2022-08-15
Retrieved May 16, 2022, from https:// upcoming-american-society-of-gene-and-cell-therapys-25th-annual-meeting/  A First-in-Human Phase 1 Clinical Gene Therapy Trial for the Treatment of Heart Failure Using a Novel Re-Engineered Adeno-Associated Vector.
The survival period is expected to be extended by nearly 1 year! Don’t forget to do this after you have lung cancer
Time of Update: 2021-11-04
According to a study published in Chest, the official journal of the American College of Physicians (ACCP), people who quit smoking after a diagnosis of non-small cell lung cancer (NSCLC) prolonged their lifespan by nearly one year compared to those who continued to smoke .
Nat Chem Biol | Rao Yu/Ying Meidan team designed CDK2 degradation agent and applied it to AML differentiation treatment
Time of Update: 2021-03-23
This work reports a new type of CDK2 selective degrading agent that achieves high-efficiency and low-toxicity in AML cell differentiation therapy, and provides a potential differentiation therapy for AML therapy.
Notice of the Tianjin Municipal Market Supervision and Administration Commission on the failure of the first batch of municipal supervision and sampling in the food production sector (1st in 2019
Time of Update: 2021-01-10
A total of 13 batches of 885 batches of samples, such as pastries, food additives, cooking oil, oil and their products, condiments, meat products, beverages, biscuits, frozen beverages, potatoes and puffed food, tea and related products, liquor, fried food and nut products, sugar, etc., sample inspection items qualified samples 882 batches, non-conforming samples 3 batches.